Faculty Profiles

Dr. Bocheng Wu

Wu, Bocheng (Principal), Percent Contribution: %70, Lewis, Karen A (Co-Principal), Percent Contribution: %30. Research Enhancement Program, TXST, Texas State University, $24000. (Submitted: October 2025, Funded: December 2025 - May 2027). Grant.
Lewis, Karen A (Co-Principal), Percent Contribution: %30, Wu, Bocheng (Principal), Percent Contribution: %70. Lead optimization of TOX inhibitor to reverse the T cell exhaustion in cancer treatment, Texas State University, $24000. (Funded: December 15, 2025 - January 1, 2027). Grant.

Walunj, D., Wu, B., Olugbami, J., Johnston, A., Kern, R., Nelson, T. J., … Oyelere, A. K. (n.d.). Repositioning Antihistamine for Cancer Therapy: Clemizole as a Template for the Design of Liver Tissue-Targeting Epigenetic Modifying Agents. Journal of Medicinal Chemistry.
Wu, B., Koehler, A. N., & Westcott, P. M. K. (2024). New opportunities to overcome T cell dysfunction: the role of transcription factors and how to target them. Trends in Biochemical Sciences, 49(11), 1014–1029. https://doi.org/10.1016/j.tibs.2024.08.002
Owumi, S., Olanlokun, J., Wu, B., Duro-Ladipo, A., Oyelere, S., Khan, S., & Oyelere, A. (2024). Elucidation of the Active Agents in a West African Ground Herbal Medicine Formulation That Elicit Antimalarial Activities in In Vitro and In Vivo Models. Molecules, 29(23), 5658. https://doi.org/10.3390/molecules29235658
Kohrt, S. E., Novak, E. J., Tapadar, S., Wu, B., Strope, J., Asante, Y., … Gryder, B. E. (2024). Small-molecule disruption of androgen receptor–dependent chromatin clusters. Proceedings of the National Academy of Sciences, 121(48). https://doi.org/10.1073/pnas.2406239121
Wu, B., Tapadar, S., Ruan, Z., Sun, C. Q., Arnold, R. S., Johnston, A., … Oyelere, A. K. (2024). A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy. ACS Pharmacology & Translational Science, 7(10), 3155–3169. https://doi.org/10.1021/acsptsci.4c00358